Yttrium-90-labelled somatostatin-analogue for cancer treatment. (Record no. 9450522)

MARC details
000 -LEADER
fixed length control field 01263 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513135142.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199803s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0140-6736
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/s0140-6736(05)78355-0
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Otte, A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19980318
245 00 - TITLE STATEMENT
Title Yttrium-90-labelled somatostatin-analogue for cancer treatment.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Lancet (London, England)
Date of publication, distribution, etc. Feb 1998
300 ## - PHYSICAL DESCRIPTION
Extent 417-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neuroendocrine Tumors
General subdivision chemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Octreotide
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Radiopharmaceuticals
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Somatostatin
General subdivision analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Yttrium Radioisotopes
General subdivision therapeutic use
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mueller-Brand, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dellas, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nitzsche, E U
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Herrmann, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Maecke, H R
773 0# - HOST ITEM ENTRY
Title Lancet (London, England)
Related parts vol. 351
-- no. 9100
-- p. 417-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/s0140-6736(05)78355-0">https://doi.org/10.1016/s0140-6736(05)78355-0</a>
Public note Available from publisher's website

No items available.